Ligand validation:5T72

TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5T72_TRS_A_304	9%	54%	0.235	0.728	0.65	1.12	-	1	6	0	100%	1
6SB7_TRS_A_309	38%	76%	0.226	0.928	0.39	0.54	-	-	0	0	100%	0.47
6PDV_TRS_A_303	27%	6%	0.208	0.853	1.45	3.47	1	5	2	0	100%	1
5T71_TRS_A_304	5%	44%	0.29	0.684	0.69	1.47	-	2	6	0	100%	1
5T74_TRS_A_304	3%	62%	0.304	0.647	0.36	1.09	-	1	4	0	100%	1
7SV8_TRS_A_301	0%	40%	0.518	0.531	0.97	1.34	-	1	7	0	100%	1
4RT5_TRS_A_203	100%	58%	0.039	0.992	0.67	0.93	-	-	1	0	100%	1
1FHF_TRS_B_4001	100%	21%	0.034	0.986	1.79	1.55	1	2	0	0	100%	1
4MY0_TRS_F_401	100%	70%	0.04	0.981	0.33	0.82	-	-	0	0	100%	1
3IWF_TRS_B_109	100%	76%	0.043	0.983	0.38	0.55	-	-	0	0	100%	1
6R55_TRS_A_301	99%	76%	0.047	0.976	0.3	0.64	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.